Plasmin resulted in increased neutrophil adherence to cultured ovine pulmonary artery endothelial cell monolayers in a concentration-dependent manner (102-40'7 M). The adherence response increased fivefold above baseline within 60 min after addition of plasmin (10-8 M) and the response persisted up to 30 min after removal of plasmin. The neutrophil adherence was mediated by the action of plasmin on neutrophils rather than endothelial cells. The response was the result of an increase in functional activity of CD18 neutrophil cell surface adhesive glycoprotein. Neutrophil adherence was inhibited by pretreatment of neutrophils with MAbs IB4 and 60.3 targeted against the ,B chain of the CD18, whereas control isotypic MAb 60.5 against HLA class I antigen had no effect. The plasmin catalytic site was not involved in the response. Lys-plasminogen had reduced adherence-promoting activity relative to plasmin, whereas glu-plasminogen had no effect. Elastase-derived plasminogen fragments corresponding to kringle 1+2+3 and kringle 4 (both of which contained the lysine-binding sites) possessed neutrophil adherence-promoting activities similar to plasmin, whereas miniplasminogen (which contains the catalytic site but no lysine-binding sites) had minimal effect, indicating the involvement of lysine-binding sites in the response. Blocking lysine-bihding sites of plasmin and elastase-derived plasminogen fragments with tranexamic acid (IC50 of 5 mM) inhibited neutrophil adherence. A monospecific polyclonal antibody against the lysine-binding sites also reduced the neutrophil adherence-promoting activity of plasmin. The results indicate that plasmin induces neutrophil adherence to the endothelium and that the effect is mediated by lysine-binding sites on plasmin.
Introduction
Plasmin, a serine protease, has a well-defined role in fibrinolysis (1) (2) (3) . Cleavage of the Arg(560)-Val(56 1) bond of plasminogen results in the generation of plasmin, a reaction catalyzed by urokinase and tissue plasminogen activator (1) 48,000-63,000) chain (2) . The catalytic site resides in the light chain (2) . The heavy chain consists of five homologous domains called "kringles," the first four of which contain the lysine-binding sites (LBS)' (2, 4) . The native molecule, gluplasminogen, has one high-affinity LBS and five low-affinity LBS, whereas the modified plasminogen, lys-plasminogen, has one high-, one intermediate-, and four low-affinity LBS (5) (6) (7) . The exact number of LBS on plasmin is presently unknown. The LBS on plasmin and plasminogen mediate binding to fibrin (8) and to cell surfaces (9) (10) (11) (12) (13) (14) , thereby enhancing the activation rate of plasminogen (10, 12) . The inactivation of plasmin by plasma protease inhibitor (a2-plasmin inhibitor) is also a LBS-dependent process (2) .
Alpha2-antiplasmin rapidly inhibits the plasmin generated in the circulation; however, the inhibitory capacity of a2-antiplasmin may be exceeded during generation of plasmin in pathological conditions such as disseminated intravascular coagulation, liver disease, fibrinolytic activator therapy, and pulmonary microembolism (1) . Circulating plasmin may participate in the inflammatory response by an action on bloodformed elements and endothelial cells. It is known that plasminogen binds avidly to endothelial cells and platelets in a specific, reversible, and saturable manner (10, 1 1) by receptors that appear to be distinct from thrombin receptors (9) . Plasmin (> 1 U/ml) induces platelet aggregation, protein phosphorylation, calcium mobilization, and activation of phospholipase C and protein kinase C in platelets (15, 16) . In addition, the generation of plasmin after intravascular fibrin entrapment may contribute to the vascular sequestration of neutrophils (17, 18) .
An adhesive interaction between neutrophils and vascular endothelium is a key event in acute inflammation. Inflammatory mediators (e.g., thrombin, leukotriene B4 [LTB4], tumor necrosis factor [TNF], IL 1, C5a) modulate neutrophil adhesiveness (17) (18) (19) (20) (21) (22) (23) (24) (25) , which, in large part, is mediated by the cell surface glycoprotein (CD 18) on neutrophils (22, 26 ). This conclusion is based on the findings that neutrophils obtained from patients with genetic CD1 8 deficiency do not adhere to endothelium when stimulated (26) and that MAbs directed against CD 18 prevent neutrophil adhesion to the endothelium (26) . Because fibrinolysis and inflammation often occur simultaneously (16), in this study, we have examined whether this key fibrinolytic enzyme possesses a neutrophil adhesion-promoting activity. We also examined the characteristics of the response (i.e., roles of neutrophil versus endothelium and of CD1 8 in mediating the adherence) and the specific molecular domains on plasmin responsible for neutrophil adhesion.
Methods
Plasmin and plasminogen preparations. Porcine plasmin, purchased from Sigma Chemical Co. (St. Louis, MO), was dissolved at concentration of 10-6 M in 10 mM Tris, 150 mM NaCl at pH 7.4, and stored at -70°C. The catalytic activity of plasmin was determined using H-D-Nle-HHT-Lys-pNa.2AcOH (Spectrozyme-PI) in a plasmin-specific chromogenic substrate assay (American Diagnostica, Greenwich, CT). Detailed methods for the catalytic assay have been previously described (27) . In some cases, the effects ofhuman plasmin were examined. Human plasmin and native glu-plasminogen were prepared as described previously (28) . Lys-plasminogen was supplied by Dr. F. Toulemonde, Choay Laboratories, Paris, France.
Inhibition ofcatalytic activity ofplasmin. The catalytic site of plasmin was inactivated with diisopropylfluorophosphate (DFP), Trasylol, and a2-plasmin inhibitor (a2-PI) as described below:
(a) DFP (0.2 M in 2-propanol) was added to plasmin (10-6 M) at a DFP/plasmin ratio of 5:95 (vol/vol). After 5 h, at 4°C, the DFP-plasmin solution was dialyzed extensively against 0.05 M Tris buffer (pH 7.4). DFP-plasmin was aliquoted and frozen at -70°C.
(b) Trasylol (Sigma Chemical Co.) was added to plasmin using 10:1 (U/U) ratio for 10 min at 20°C. The Trasylol-treated plasmin was subjected to extensive dialysis. Both DFP-and Trasylol-inhibited plasmin had < 0.1% residual plasmin activity.
( Neutrophil isolation and labeling. The isolation of sheep neutrophils involved two steps (32) : hemolysis of erythrocytes in leukocyterich fraction and separation ofneutrophils from other cells by centrifugation over a continuous Percoll gradient. The purity of neutrophils was > 95%, as indicated by Wright-Giemsa stain. Viability of> 98% of the isolated neutrophils was demonstrated using trypan blue exclusion. Freshly isolated neutrophils were suspended in Hanks' solution containing 25 mM Hepes, 1 mg/ml BSA and 20 mM EDTA for 51-Chromium (5'Cr, New England Nuclear, Boston, MA) labeling. 5'Cr (0.2-0.5 ,uCi) per 106 neutrophils was added to the neutrophil suspension. The neutrophils and 5'Cr were incubated for 30 min at 37°C. Free 5'Cr was removed by washing with Hanks' solution plus 20 mM EDTA and the pelleted neutrophils from the last centrifugation (450 g, 5 min, 4C) were resuspended in an appropriate volume to yield a cell concentration of 2 X 106 cells/ml. After labeling, > 98% of the neutrophils were found to exclude trypan blue and these cells showed minimal basal adherence (< 5% adherence) to the endothelium.
For isolation of human neutrophils, whole blood was collected from healthy donors by venipuncture into acid-citrate-dextrose and centrifuged to obtain a buffy coat. The buffy coat was separated into neutrophil-rich fraction by dextran sedimentation, followed by FicollHypaque gradient centrifugation, and hypotonic lysis of erythrocytes. The washed neutrophils were suspended in HBSS without ions, with 25 mM Hepes, 20 mM EDTA, and 0.1% BSA and the pH was adjusted to 7.4. The purity of neutrophils was over 98% and their viability was > 99%. The cells were labeled with 5'Cr as described above.
Endothelial cell culture. Sheep pulmonary artery endothelial cells (SPAE) were obtained as previously described (29) . The cells were shown to be endothelial in origin by the presence ofFactor VIII-related antigen, angiotensin converting enzyme activity, acylated low-density lipoprotein binding, and exhibited typical cobblestone morphology. Endothelial cells were plated at 105 cells/ml and grown to confluence while being maintained on DME plus 10% FCS. Multiple passage (P8-P18) of SPAE were used. Endothelial cell monolayers were used within 3 d of seeding.
Human umbilical vein endothelial cells (HUVEC) cells were prepared by collagenase treatment. HUVEC were maintained in RPMI 1640 with 20% fetal bovine serum, 6.5 Ag/ml retinal-derived growth factor, and 75 ,g/ml heparin. Cells were plated in 16-mm diameter wells in 24-well plates at 105 cells/well. Confluent monolayers were formed within 3 d of seeding when the study was carried out.
Neutrophil adherence assay. The culture medium was aspirated and endothelial cells were washed with DME. To each well, 100 JAI of 5'Cr-labeled sheep neutrophils were added, followed by the stimulant (100-,ul volume). We assessed whether plasmin exerted its adherence-promoting effects on endothelial cells and/or neutrophils. In the first experiment, endothelial cell monolayers were pretreated with plasmin before adherence assay carried out with freshly obtained neutrophils (Table I) . Adherence of neutrophils to plasmin-pretreated endothelial cell monolayers was similar to basal adherence. Addition of plasmin to washed endothelial cells that had been pretreated with plasmin resulted in an adherence response. We next incubated neutrophils with plasmin for 30 min and washed the neutrophils before their addition to unstimulated endothelial cell monolayer. These neutrophils demonstrated increased adherence to the endothelium, which was comparable to that observed when plasmin (10-8 M) was added to the mixed cell cultures of endothelial cells and neutrophils. Neutrophils remained viable during the 30-min plasmin incubation period before washing.
The effect of plasmin on neutrophils was studied using sheep neutrophils and endothelial cells; however, the response was not species dependent. Human plasmin induced a comparable adhesion of human neutrophils to HUVEC (percent adherence increased from basal value of 2±1 to 18±1% [n = 6] with 10-8 M plasmin). Moreover, human plasmin (10-8 M) did not significantly increase adherence of human neutrophils to human ocular fibroblasts (basal adherence of 3±0.3 to 5±0.3% with plasmin) (n = 3).
We determined whether the plasmin-induced adhesion of neutrophil was mediated by increased CD18 activity of neutrophils by assessing the response in the presence of antibodies against the # chain of the CD 1 8 neutrophil adhesive glycoprotein complex (MAbs 60.3 and IB4). The data are summarized in Table II . Both MAbs 60.3 and IB4 inhibited the adhesion of neutrophil induced by plasmin. In contrast, the isotypic control MAb 60.5 (targeted against the HLA class I antigen on peripheral leukocytes) did not reduce neutrophil adherence, indicating the specificity of the inhibitory effects of MAbs 60.3 and IB4. We examined whether plasmin resulted in an increased expression of CD 18 on neutrophil cell membrane, and thereby contributing to the CD I 8-dependent neutrophil adhe- Figure 3 . Phase-contrast micrographs (X200) of neutrophil adhesion to cultured endothelial cell monolayer (a) Control SPAE cell monolayer (EC), (b) after adding sheep neutrophils (106 total) suspended in DME, added to confluent endothelial monolayers 60 min and then washed three times, few neutrophils are adherent, (c) increased number of neutrophils were attached to endothelial monolayer after adding plasmin (10-8 M) for 60 min and subsequently washing three times (note that the integrity of endothelial monolayer was not affected by plasmin), and (d) an increased number of neutrophils were aggregated and adherent to the endothelial monolayer after addition of 30 ng PMA.
sion. FACS analysis using FITC-IB4 on plasmin-stimulated neutrophils indicated that plasmin did not increase CD1 8 expression. The mean channel of fluorescence for unstimulated sheep neutrophils was 135, and this value was not different from value of 128 after treatment with plasmin (10-8 M) for 60 min (n = 3). In contrast, stimulation with PMA (30 ng/ml) for 15 min resulted in a threefold increase of mean channel fluorescence.
The time course of the reversibility plasmin's effect on neutrophils was examined by washing plasmin-treated neutrophils to remove residual plasmin and adding fresh DME to assay wells and incubating them for varying time intervals at 37°C. Neutrophil adherence remained elevated above basal adherence up to 30 min after plasmin challenge (Fig. 4) .
The catalytic site of plasmin was blocked irreversibly with either DFP, Trasylol, or a2-PI to determine whether the active site on plasmin is a determinant of increased neutrophil adhesiveness. The catalytic activity of plasmin was inhibited in each case by > 99.9%. DFP treatment did not significantly affect the ability of plasmin to induce neutrophil adherence (percent adherence of 16±3% vs. adherence induced by plasmin of 20±3%) (Fig. 5) . Trasylol (a serine protease inhibitor of larger molecular size, M, = 6,500) also did not reduce the adherence (Fig. 5) ; moreover, addition of excess Trasylol (150 U/ml) to plasmin (10-8 M) did not modify the plasmin effect (percent adherence = 18±1%). In contrast, a2-PI inhibited the effect of plasmin in promoting neutrophil adherence (percent adherence of 7±2%) (Fig. 5 ). Lys-plasminogen (plasminogen minus residues 1-76) M) also possessed the ability to induce neutrophil adherence (percent adherence of 18±0.3% vs. active plasmin value of 29±3%; n = 3). The effect of plasmin was greater than lysplasminogen at 10-8 M (P < 0.05). Unlike the lys-plasminogen, glu-plasminogen (10-7 or 10-8 M) (the native molecule) did not have an adherence-inducing effect (percent adherence of 7±1%). The plasmin contamination of these two plasminogen preparations was < 0. 1% as assessed by the chromogenic substrate assay (see Methods). The plasmin specificity of the response was further demonstrated by testing two kringle-containing proteins, tissue plasminogen activator (human tissue plasminogen activator purchased from American Diagnostica) and human urokinase (WinKinase; 250,000 U/vial, from Winthrop Labs, Rensselaer, NY) in the adherence assay. Urokinase (n = 3) and tissue plasminogen activator (n = 3) at 10-8 M had no stimulatory effect (percent adherence of 5±0.2 and 5±0.4%, respectively) compared with a control adherence of 5±1% (n = 3) and 1o-8 M plasmin response of 19±2% (n = 3).
Three purified elastase-digested plasminogen fragments (see Introduction) were used to examine the molecular domain of plasmin responsible for the neutrophil adherence-inducing activity: (a) kringle 1+2+3 (K1+2+3), (b) kringle 4 (K4), and (c) miniplasminogen (K5 + the light chain). These plasminogen fragments were used at equivalent concentrations of 10-8 M (the residual plasmin activity was < 0.1% in each kringle fragment). The neutrophil adherence-inducing responses were compared with native plasmin. Both K1+2+3 and K4 had stimulatory effects (Table III) , and responses were similar to native enzyme. In contrast, K5 + the light chain, which lacks LBS, had no significant effect (Table III) . Using a mixture of miniplasminogen and miniplasmin, neutrophil adherence response was identical to that of miniplasminogen (percent adherence = 7±1% [n = 7]). The role of the LBS in plasmin-induced neutrophil adherence was further evaluated using the LBS ligand, tranexamic acid (TX), which inhibits plasminogen binding to fibrinogen, fibrin, and endothelial cells (8, 10) . Viability of neutrophils was > 99% by trypan blue exclusion after incubation period of 60 min with TX. The capacity of TX to inhibit the effect of plasmin was concentration dependent (Fig. 6) . The IC50 was 5 mM and adherence was not affected by TX concentrations < 0.01 mM. TX reduced the adherent response induced by plasmin and by K1+2+3 and K4 (Table IV) . The monospecific polyclonal antibody directed against the K1+2+3 LBS complexed with plasmin also produced 47% inhibition of adherence (Table V) .
Discussion
This study demonstrates that plasmin induces neutrophil adherence to cultured endothelial cell monolayers. Plasmin exerts its adherence-promoting effect by an action on neutrophils rather than endothelial cells since preincubation ofendothelial cells with plasmin did not result in increased endotheHal adhesiveness. The adhesive response was independent of the plasmin catalytic activity since the DFP-or Trasyloltreated plasmin induced a similar response as native plasmin. However, the 67-kD serine protease inhibitor, a2-PI (which complexes with a larger portion of plasmin molecule) markedly reduced plasmin-induced neutrophil adherence. a2-PI blocks the catalytic site and also interferes with the LBS, an effect related to its large molecular size (3) . The finding that a2-PI inhibited the plasmin-induced adherence response suggests that noncatalytic regions of plasmin that bind to a2-PI such as LBS may mediate the response. irreversibly blocked with either DFP, Trasylol, or a2-PI. In all cases, the catalytic activity of plasmin was reduced > 99.9%. Note that only a2-PI inhibited plasmin response, whereas DFP-plasmin and Trasylol-plasmin had an adherence-promoting effect compared with plasmin. Each point represents the average of eight replicate wells. Several other lines of evidence support the conclusion that LBS on plasmin are crucial in mediating the neutrophil adherence-promoting activity of plasmin: (a) fragments K1+2+3 and K4 containing LBS possessed identical adherence-promoting activity to native plasmin, whereas the elastase-derived fragment lacking LBS (K5 + light chain) had no effect, (b) the adherence-inducing activity of plasmin and of the fragments was inhibited by TX that binds to LBS; and (c) a monospecific polyclonal antibody directed against the LBS of K1+2+3 markedly reduced the plasmin-induced neutrophil adherence.
There are two classes of LBS on kringle 1+2+3, one site with high affinity (Kd = 9 ,uM) for the lysine analog e-amino caproic acid, and others with low affinity (Kd = 5 mM) (5), all of which may participate in inducing the neutrophil adherence. Note, however, that although the K4 fragment possesses neutrophil adherence-promoting activity, this may be applicable only to in vitro conditions because the LBS on kringle 4 of plasmin is unoccupied in the presence of fibrinogen and a2-PI (34). Our observation that plasmin inhibited with a2-PI does not cause neutrophil adherence indicates that LBS on kringle 4 of the intact plasmin molecule does not participate in the ad- herence-promoting response. This is in agreement with the concept that LBS on K4 is not normally accessible (34). However, this site becomes accessible in the elastase-derived K4 fragment (3, 34), which probably accounts for the activity of K4 in inducing neutrophil adherence. The response was specific to plasmin because glu-plasminogen, the native proenzyme, did not induce neutrophil adherence. The observation that lys-plasminogen lacking amino acids 1-76 (which is generated during fibrinolytic activation [2, 3] ) produced neutrophil adherence but to a lesser extent than plasmin, supports the notion that neutrophil adhesion can occur as consequence of plasmin generation. The greater potency of plasmin versus lys-plasminogen may be the result of a specific conformational change occurring in the plasmin molecule. This altered LBS on plasmin is sufficient to explain the specificity of plasmin in eliciting the adhesion response. The lack of neutrophil adherence with glu-plasminogen is consistent with the observed differences in LBS binding affini- ties to fibrin and fibrinogen seen with lys-plasminogen versus glu-plasminogen (8) . The specificity of the response to LBS of plasmin was supported by our finding that urokinase and tissue plasminogen activator, proteins with kringle structures, did not stimulate neutrophil adherence. Thrombin has also been shown to cause neutrophil adherence to endothelium (23, 29) ; however, thrombin, unlike plasmin, exerts its effects on the endothelium (23, 29) by expression of adhesive sites on the endothelium (29) and by generation of mediators (23) . Plasmin exerts its effect on neutrophils and does not increase endothelial adhesiveness. The action of plasmin is independent ofits catalytic site, whereas thrombin's response requires the catalytic site because antithrombin III and hirudin-inactivated thrombin inhibited neutrophil adherence induced by thrombin (29) .
The CD1 8 glycoprotein complex of peripheral leukocyte is an important determinant of leukocyte adhesion to the endothelium (21, 26, 30) . MAbs IB4 and 60.3 directed against the f# chain of CD18 complex (21, 35) inhibited the plasmin-induced neutrophil adherence. Therefore, neutrophil adherence induced by plasmin is mediated by increased CD1 8 activity and this adhesion domain resides on the ,B chain ofthe heterodimer complex. The inhibitory response is specific because the control MAb 60.5 did not reduce neutrophil adherence.
Although plasmin resulted in neutrophil adhesion, it did not increase neutrophil CD 18 expression as assessed by FACS analysis; therefore, the adherence response is likely mediated by an increased functional activity of the neutrophil CD18 without an increase in glycoprotein expression. In previous studies, quantitative changes in CD 18 expression also do not correlate well with the functional adhesive activity of CD18 (30) . For example, a temperature change from 4 to 37°C caused an increase in CD18 expression but did not increase neutrophil adherence (36) . Moreover, stimulation of cytoplasts (neutrophils without granules) did not induce CD1 8 expression, although cytoplasts were capable of adhering to endothelium via increased CD1 8 activity (37). Detmers et al. (38) have reported a temporal correlation between formation of CR3 microaggregates on neutrophil cell surface and CR3 binding activity, suggesting that CD1 8 clustering may be responsible for increased CD1 8 functional activity.
In contrast to the effect ofplasmin in promoting neutrophil adherence to the endothelium, plasmin did not result in neutrophil adherence to a confluent layer of ocular fibroblasts. This result indicates the specificity of the response with respect of adherence to endothelial cells, and also suggests that an interaction occurs between the neutrophil adhesive glycoprotein CD1 8 and sites on the endothelium.
The action of plasmin in inducing neutrophil adherence is comparable in magnitude and time course to other neutrophil adhesion-promoting mediators such as C5a and FLMP, which act primarily on neutrophils (17) . These agents also increase neutrophil adhesiveness over a short time (i.e., within 1 h). The rapidity of the adherence response is compatible with increased functional activity of CD1 8 without translocation of CD1 8 glycoprotein from the cytoplasmic storage granules to the cell surface (39) . The persistence of the plasmin effect for up to 30 min after washing is in contrast to effects of other mediators such as C5a (17) and LTB4 (20) , which result in a rapid modulation of neutrophil adherence.
The results of this study may have pathophysiological significance because the generation of plasmin can have consequences in the inflammatory response (1, 40) . It is known that fibrinolytic activation leading to free plasmin generation (1) induces proteolysis of plasma proteins (17, 18) and platelet aggregation and activation, (16, 41, 42) . In addition, as these results indicate, free plasmin induces neutrophil adherence, which may result in intravascular neutrophil sequestration and may have a proinflammatory role at the vessel wall surface.
